{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:42:01Z","timestamp":1788561721218,"version":"build-2803163510"},"reference-count":26,"publisher":"Japanese Circulation Society","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2022,6,24]]},"DOI":"10.1253\/circj.cj-22-0118","type":"journal-article","created":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T22:10:50Z","timestamp":1653084650000},"page":"1113-1120","source":"Crossref","is-referenced-by-count":14,"title":["Extracardiac Biopsy Sensitivity in Transthyretin Amyloidosis Cardiomyopathy Patients With Positive &lt;sup&gt;99 m&lt;\/sup&gt;Tc-Labeled Pyrophosphate Scintigraphy Findings"],"prefix":"10.1253","volume":"86","author":[{"given":"Masato","family":"Nishi","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seiji","family":"Takashio","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mami","family":"Morioka","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Fujiyama","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Nakashima","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Hirakawa","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hanatani","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Usuku","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichiro","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kidoh","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seitaro","family":"Oda","sequence":"additional","affiliation":[{"name":"Department of Diagnostic Radiology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Gushima","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Fukushima","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Plastic Surgery, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuharu","family":"Ueda","sequence":"additional","affiliation":[{"name":"Department of Neurology, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Tsujita","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kumamoto University"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Izumiya Y, Takashio S, Oda S, Yamashita Y, Tsujita K. Recent advances in diagnosis and treatment of cardiac amyloidosis. <i>J Cardiol<\/i> 2018; 71: 135\u2013143.","DOI":"10.1016\/j.jjcc.2017.10.003"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Maurer MS, Elliott P, Comenzo R, Semigran M, Rapezzi C. Addressing common questions encountered in the diagnosis and management of cardiac amyloidosis. <i>Circulation<\/i> 2017; 135: 1357\u20131377.","DOI":"10.1161\/CIRCULATIONAHA.116.024438"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Gonz\u00e1lez-L\u00f3pez E, Gallego-Delgado M, Guzzo-Merello G, de Haro-Del Moral FJ, Cobo-Marcos M, Robles C, et al. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. <i>Eur Heart J<\/i> 2015; 36: 2585\u20132594.","DOI":"10.1093\/eurheartj\/ehv338"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Nitsche C, Scully PR, Patel KP, Kammerlander AA, Koschutnik M, Dona C, et al. Prevalence and outcomes of concomitant aortic stenosis and cardiac amyloidosis. <i>J Am Coll Cardiol<\/i> 2021; 77: 128\u2013139.","DOI":"10.1016\/j.jacc.2020.11.006"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Benson MD, Dasgupta NR, Rissing SM, Smith J, Feigenbaum H. Safety and efficacy of a TTR specific antisense oligonucleotide in patients with transthyretin amyloid cardiomyopathy. <i>Amyloid<\/i> 2017; 24: 217\u2013223.","DOI":"10.1080\/13506129.2017.1374946"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Kittleson MM, Maurer MS, Ambardekar AV, Bullock-Palmer RP, Chang PP, Eisen HJ, et al. Cardiac amyloidosis: Evolving diagnosis and management: A scientific statement from the American Heart Association. <i>Circulation<\/i> 2020; 142: e7\u2013e22.","DOI":"10.1161\/CIR.0000000000000792"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maurer MS, Schwartz JH, Gundapaneni B, Elliott PM, Merlini G, Waddington-Cruz M, et al. Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy. <i>N Engl J Med<\/i> 2018; 379: 1007\u20131016.","DOI":"10.1056\/NEJMoa1805689"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Solomon SD, Adams D, Kristen A, Grogan M, Gonz\u00e1lez-Duarte A, Maurer MS, et al. Effects of patisiran, an RNA interference therapeutic, on cardiac parameters in patients with hereditary transthyretin-mediated amyloidosis. <i>Circulation<\/i> 2019; 139: 431\u2013443.","DOI":"10.1161\/CIRCULATIONAHA.118.035831"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Judge DP, Heitner SB, Falk RH, Maurer MS, Shah SJ, Witteles RM, et al. Transthyretin stabilization by AG10 in symptomatic transthyretin amyloid cardiomyopathy. <i>J Am Coll Cardiol<\/i> 2019; 74: 285\u2013295.","DOI":"10.1016\/j.jacc.2019.03.012"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Gillmore JD, Maurer MS, Falk RH, Merlini G, Damy T, Dispenzieri A, et al. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. <i>Circulation<\/i> 2016; 133: 2404\u20132412.","DOI":"10.1161\/CIRCULATIONAHA.116.021612"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Bokhari S, Casta\u00f1o A, Pozniakoff T, Deslisle S, Latif F, Maurer MS. (99 m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses. <i>Circ Cardiovasc Imaging<\/i> 2013; 6: 195\u2013201.","DOI":"10.1161\/CIRCIMAGING.112.000132"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Phull P, Sanchorawala V, Connors LH, Doros G, Ruberg FL, Berk JL, et al. Monoclonal gammopathy of undetermined significance in systemic transthyretin amyloidosis (ATTR). <i>Amyloid<\/i> 2018; 25: 62\u201367.","DOI":"10.1080\/13506129.2018.1436048"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Seferovi\u0107 PM, Tsutsui H, McNamara DM, Risti\u0107 AD, Basso C, Bozkurt B, et al. Heart Failure Association of the ESC, Heart Failure Society of America and Japanese Heart Failure Society Position statement on endomyocardial biopsy. <i>Eur J Heart Fail<\/i> 2021; 23: 854\u2013871.","DOI":"10.1002\/ejhf.2190"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Quarta CC, Gonzalez-Lopez E, Gilbertson JA, Botcher N, Rowczenio D, Petrie A, et al. Diagnostic sensitivity of abdominal fat aspiration in cardiac amyloidosis. <i>Eur Heart J<\/i> 2017; 38: 1905\u20131908.","DOI":"10.1093\/eurheartj\/ehx047"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ueda M, Horibata Y, Shono M, Misumi Y, Oshima T, Su Y, et al. Clinicopathological features of senile systemic amyloidosis: An ante- and post-mortem study. <i>Mod Pathol<\/i> 2011; 24: 1533\u20131544.","DOI":"10.1038\/modpathol.2011.117"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Ikeda S, Sekijima Y, Tojo K, Koyama J. Diagnostic value of abdominal wall fat pad biopsy in senile systemic amyloidosis. <i>Amyloid<\/i> 2011; 18: 211\u2013215.","DOI":"10.3109\/13506129.2011.623199"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Dorbala S, Ando Y, Bokhari S, Dispenzieri A, Falk RH, Ferrari VA, et al. ASNC\/AHA\/ASE\/EANM\/HFSA\/ISA\/SCMR\/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging. <i>J Nucl Cardiol<\/i> 2019; 26: 2065\u20132123.","DOI":"10.1007\/s12350-019-01760-6"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Iida T, Yamano H, Nakase H. Systemic amyloidosis with gastrointestinal involvement: Diagnosis from endoscopic and histological views. <i>J Gastroenterol Hepatol<\/i> 2018; 33: 583\u2013590.","DOI":"10.1111\/jgh.13996"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Takashio S, Izumiya Y, Jinnin M, Yamamuro M, Kojima S, Ihn H, et al. Diagnostic and prognostic value of subcutaneous tissue biopsy in patients with cardiac amyloidosis. <i>Am J Cardiol<\/i> 2012; 110: 1507\u20131511.","DOI":"10.1016\/j.amjcard.2012.06.059"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Endo J, Sano M, Izumiya Y, Tsujita K, Nakamura K, Tahara N, et al. A statement on the appropriate administration of tafamidis in patients with transthyretin cardiac amyloidosis. <i>Circ J<\/i> 2019; 84: 15\u201317.","DOI":"10.1253\/circj.CJ-19-0811"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: Differences in complication rate and diagnostic performance. <i>Circulation<\/i> 2010; 122: 900\u2013909.","DOI":"10.1161\/CIRCULATIONAHA.109.924167"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekijima Y, et al. Nationwide survey of 741 patients with systemic amyloid light-chain amyloidosis in Japan. <i>Intern Med<\/i> 2018; 57: 181\u2013187.","DOI":"10.2169\/internalmedicine.9206-17"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kristen AV, Brokbals E, Aus dem Siepen F, Bauer R, Hein S, Aurich M, et al. Cardiac amyloid load: A prognostic and predictive biomarker in patients with light-chain amyloidosis. <i>J Am Coll Cardiol<\/i> 2016; 68: 13\u201324.","DOI":"10.1016\/j.jacc.2016.04.035"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Grogan M, Scott CG, Kyle RA, Zeldenrust SR, Gertz MA, Lin G, et al. Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system. <i>J Am Coll Cardiol<\/i> 2016; 68: 1014\u20131020.","DOI":"10.1016\/j.jacc.2016.06.033"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Castano A, Haq M, Narotsky DL, Goldsmith J, Weinberg RL, Morgenstern R, et al. Multicenter study of planar technetium 99 m pyrophosphate cardiac imaging: Predicting survival for patients with ATTR cardiac amyloidosis. <i>JAMA Cardiol<\/i> 2016; 1: 880\u2013889.","DOI":"10.1001\/jamacardio.2016.2839"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Connors LH, Sam F, Skinner M, Salinaro F, Sun F, Ruberg FL, et al. Heart failure resulting from age-related cardiac amyloid disease associated with wild-type transthyretin: A prospective, observational cohort study. <i>Circulation<\/i> 2016; 133: 282\u2013290.","DOI":"10.1161\/CIRCULATIONAHA.115.018852"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/7\/86_CJ-22-0118\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,25]],"date-time":"2022-06-25T04:45:12Z","timestamp":1656132312000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/86\/7\/86_CJ-22-0118\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,24]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-22-0118","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,24]]},"article-number":"CJ-22-0118"}}